Joined January 2014
Photos and videos
Two PEN leaders, Kara Rayburn and Aicha Diallo, named to 2026 40 Under 40 in Cancer. Congrats! #40Under40InCancer #PatientEmpowerment #CancerAdvocacy #HealthEquity #MPNHero
20
How can discussing treatment goals improve #prostatecancer care? Dr. Sentana Lledo from @DanaFarber shares why it’s essential for patients to communicate their priorities & preferences, allowing for collaboration to choose the most appropriate treatment. ow.ly/Srh850Z9WJl
17
What are the key questions #ovariancancer patients should ask about treatment options? Dr. Kevin Elias from @clevelandclinic provides an overview of options, including surgery, chemotherapy and targeted therapies. See more from INSIST! Ovarian Cancer: bit.ly/4vFjzzJ
22
Most remember ASCO 2026 breakthroughs; power4patients remembers the conversations, stories, and advocates driving change. #ASCO2026 #PatientAdvocacy #HealthEquity #CancerCommunity #EveryEncounterEmpowers #PowerfulPatients
15
Dr. Shivani Handa from @OSUCCC_James explains molecular testing and why it is important for MPN patients. #mpnsm
38
Dr. Kevin Elias from @ClevelandClinic discusses the targeted therapy options available for #ovariancancer patients and how they work.
11
What are #prostatecancer treatment side effects? Dr. Daniel Sentana Lledo of @DanaFarber explains common issues, including urinary and sexual changes, and shares why communication with your healthcare team is essential to managing symptoms effectively. ow.ly/1GFK50Z7AAN
29
La Dra. Virginia Haoyu Sun, de @harvardmed, profundiza en cómo utilizar la IA de manera segura y responsable. Explica de qué forma se introduce el sesgo en los sistemas de IA y qué significa realmente la confianza en las herramientas de salud digital. ow.ly/s7G550Z7aqF
22
Dr. Daniel Sentana Lledo from @DanaFarber explains how #prostatecancer clinical trials advance care, debunks misconceptions, and outlines the key questions patients should ask to understand eligibility, benefits, and risks of trial participation. ow.ly/bMhr50Z77sA #pcsm
20